{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:38:25Z","timestamp":1770971905029,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf01806187","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T01:07:44Z","timestamp":1119920864000},"page":"203-212","source":"Crossref","is-referenced-by-count":41,"title":["FISH detection of HER-2\/neu oncogene amplification in early onset breast cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"Wei-Rong","family":"Xing","sequence":"first","affiliation":[]},{"given":"Kennedy W.","family":"Gilchrist","sequence":"additional","affiliation":[]},{"given":"Charles P.","family":"Harris","sequence":"additional","affiliation":[]},{"given":"Wilner","family":"Samson","sequence":"additional","affiliation":[]},{"given":"Lorraine F.","family":"Meisner","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF01806187_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235: 177\u2013182, 1987","journal-title":"Science"},{"issue":"Supplement B","key":"BF01806187_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0305-7372(93)90007-E","volume":"19","author":"JG Klijn","year":"1993","unstructured":"Klijn JG, Berns EM, Bontenbal M, Foekens J: Cell biological factors associated with the response of breast cancer to systemic treatment. Cancer Treatment Reviews 19 (Supplement B): 45\u201363, 1993","journal-title":"Cancer Treatment Reviews"},{"key":"BF01806187_CR3","first-page":"556","volume":"51","author":"MC Paterson","year":"1991","unstructured":"Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA, Slamon DJ, Fourney RM: Correlation between c-erbB-2 amplification and risk of recurrent disease in nodenegative breast cancer. Cancer Research 51: 556\u2013567, 1991","journal-title":"Cancer Research"},{"key":"BF01806187_CR4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707\u2013712, 1989","journal-title":"Science"},{"key":"BF01806187_CR5","first-page":"6675","volume":"49","author":"I Garcia","year":"1989","unstructured":"Garcia I, Dietrich PY, Aapro M, Vauthier G, Vadas L, Engel E: Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Cancer Research 49: 6675\u20136679, 1989","journal-title":"Cancer Research"},{"key":"BF01806187_CR6","first-page":"4960","volume":"53","author":"MF Press","year":"1993","unstructured":"Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk G, Godolphin W, Sliwkowski M, Akita R, Paterson MC, Slamon DJ: HER-2\/neu expression in node-negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Research 53: 4960\u20134970, 1993","journal-title":"Cancer Research"},{"issue":"6B","key":"BF01806187_CR7","first-page":"1965","volume":"12","author":"R Molina","year":"1992","unstructured":"Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL: Expression of HER-2\/neu oncoprotein in human breast cancer: A comparison of immunohistochemical and western blot techniques. Anticancer Research 12(6B): 1965\u20131971, 1992","journal-title":"Anticancer Research"},{"key":"BF01806187_CR8","first-page":"119","volume":"13","author":"F Descotes","year":"1993","unstructured":"Descotes F, Pavy JJ, Adessi GL: Human breast cancer: Correlation study between HER-2\/neu amplification and prognostic factors in an unselected population. Anticancer Research 13: 119\u2013124, 1993","journal-title":"Anticancer Research"},{"key":"BF01806187_CR9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/1097-0142(19920815)70:4<770::AID-CNCR2820700409>3.0.CO;2-U","volume":"70","author":"J Babiak","year":"1992","unstructured":"Babiak J, Hugh J, Poppema S: Significance of c-erbB-2 amplification and DNA aneuploidy. Cancer 70: 770\u2013776, 1992","journal-title":"Cancer"},{"key":"BF01806187_CR10","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199405053301802","volume":"330","author":"HB Muss","year":"1994","unstructured":"Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koemer F, Cirrincione CT, Budman DR, Wood WC, Barcos M: c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. New Eng J Med 330: 1260\u20131266, 1994","journal-title":"New Eng J Med"},{"issue":"Supplement","key":"BF01806187_CR11","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1097-0142(19920915)70:4+<1765::AID-CNCR2820701618>3.0.CO;2-C","volume":"70","author":"SR Wolman","year":"1992","unstructured":"Wolman SR, Pauley RJ, Mohamed AN, Dawson PJ, Visscher DW, Sarker FH: Genetic markers as prognostic indicators in breast cancer. Cancer 70 (Supplement): 1765\u20131774, 1992","journal-title":"Cancer"},{"key":"BF01806187_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ijc.2910580602","volume":"58","author":"S Prost","year":"1994","unstructured":"Prost S, Le MG, Douc-Rasy S, Ahomadegbe JC, Spielmann M, Guerin M, Riou G: Association of c-erbB2-gene amplification with poor prognosis in non-inflammatory breast carcinomas but not in carcinomas of the inflammatory type. Int J Cancer 58: 763\u2013768, 1994","journal-title":"Int J Cancer"},{"key":"BF01806187_CR13","first-page":"2771","volume":"54","author":"MF Press","year":"1994","unstructured":"Press MF, Hung G, Godolphin W, Slamon DJ: Sensitivity of HER-2\/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54: 2771\u20132777, 1994","journal-title":"Cancer Res"},{"key":"BF01806187_CR14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcp\/100.4.444","volume":"100","author":"DH Farkas","year":"1993","unstructured":"Farkas DH, McMahon LW, Cai P, Umek RM: Improved quantitation of HER-2\/neu gene copy number in breast tumor-derived DNA samples. Am J Clin Path 100: 444\u2013450, 1993","journal-title":"Am J Clin Path"},{"key":"BF01806187_CR15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.2910470607","volume":"47","author":"C Dati","year":"1991","unstructured":"Dati C, Muraca R, Tazartes O, Antoniotti S, Perroteau I, Giai M, Cortese P, Sismondi P, Saglio G, De Bortoli M: c-erb-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome. Int J Cancer 47: 833\u2013838, 1991","journal-title":"Int J Cancer"},{"key":"BF01806187_CR16","first-page":"1343","volume":"14","author":"C Pechoux","year":"1994","unstructured":"Pechoux C, Chardonnet Y, Noel P: Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions. Anticancer Res 14: 1343\u20131360, 1994","journal-title":"Anticancer Res"},{"issue":"Supplement","key":"BF01806187_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/cncr.2820741326","volume":"74","author":"EG Mansour","year":"1994","unstructured":"Mansour EG, Ravdin PM, Dressler L: Prognostic factors in early breast carcinoma. Cancer 74(Supplement): 381\u2013400, 1994","journal-title":"Cancer"},{"key":"BF01806187_CR18","unstructured":"Hankey BF, Miller B, Curtis R, Kosary C: Trends in breast cancer in younger women in contrast to older woman. Journal of the National Cancer Institute Monographs (16): 7\u201314, 1994"},{"key":"BF01806187_CR19","unstructured":"Swanson GM, Lin CS: Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. Journal of the National Cancer Institute Monographs (16): 69\u201377, 1994"},{"key":"BF01806187_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00666425","volume":"28","author":"AM Bowcock","year":"1993","unstructured":"Bowcock AM: Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer. Breast Cancer Research and Treatment 28: 121\u2013135, 1993","journal-title":"Breast Cancer Research and Treatment"},{"key":"BF01806187_CR21","first-page":"476","volume":"45","author":"FZ Bischoff","year":"1993","unstructured":"Bischoff FZ, Hansen MF: Genetics of familial breast cancer. The Cancer Bulletin 45: 476\u2013482, 1993","journal-title":"The Cancer Bulletin"},{"key":"BF01806187_CR22","first-page":"95","volume":"18","author":"D Easton","year":"1993","unstructured":"Easton D, Ford D, Peto J: Inherited susceptibility to breast cancer. Cancer Surveys 18: 95\u2013113, 1993","journal-title":"Cancer Surveys"},{"key":"BF01806187_CR23","unstructured":"Albain KS, Allred DC, Clark GM: Breast cancer outcome and predictors of outcome: are there age differentials? Journal of the National Cancer Institute Monographs (16): 35\u201342, 1994"},{"key":"BF01806187_CR24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0140-6736(93)92407-K","volume":"341","author":"A Rochefordiere de la","year":"1993","unstructured":"de la Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand JC, Pouillart P, Magdelenat H, Fourquet A: Age as prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039\u20131043, 1993","journal-title":"Lancet"},{"key":"BF01806187_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-4608(93)90004-6","volume":"68","author":"W Lee","year":"1993","unstructured":"Lee W, Han K, Harris CP, Meisner LF: Detection of aneuploidy and possible deletion in paraffin-embedded rhabdomyosarcoma cells with FISH. Cancer Genetics and Cytogenetics 68: 99\u2013103, 1993","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"BF01806187_CR26","first-page":"35","volume":"40","author":"EN Imyanitov","year":"1993","unstructured":"Imyanitov EN, Chernitsa OI, Serova OM, Nikoforova IF, Pluzhnikova GF, Knyazev PG: Amplification of HER-2\/neu (erbB-2\/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients. Neoplasma 40: 35\u201339, 1993","journal-title":"Neoplasma"},{"key":"BF01806187_CR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00666584","volume":"28","author":"M Watatani","year":"1993","unstructured":"Watatani M, Nagayama K, Imanishi Y, Kurooka K, Wada T, Inui H, Hirai K, Ozaki M, Yasutomi M: Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy. Breast Cancer Research and Treatment 28: 231\u2013239, 1993","journal-title":"Breast Cancer Research and Treatment"},{"key":"BF01806187_CR28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000227221","volume":"50","author":"MA Nagai","year":"1993","unstructured":"Nagai MA, Marques LA, Torloni H, Brentani MM: Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors. Oncology 50: 412\u2013417, 1993","journal-title":"Oncology"},{"key":"BF01806187_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/gcc.2870070305","volume":"7","author":"W Lee","year":"1993","unstructured":"Lee W, Han K, Drut RM, Harris CP, Meisner LF: Use of FISH for retrospective detection of aneuploidy in multiple myeloma. Genes Chromosomes and Cancer 7: 137\u2013143, 1993","journal-title":"Genes Chromosomes and Cancer"},{"key":"BF01806187_CR30","first-page":"81","volume":"8","author":"K Han","year":"1994","unstructured":"Han K, Lee W, Harris CP, Kim W, Shim S, Meisner LF: Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH). Leukemia 8: 81\u201386, 1994","journal-title":"Leukemia"},{"key":"BF01806187_CR31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jnci\/85.3.200","volume":"85","author":"DC Allred","year":"1993","unstructured":"Allred DC, Clark GM, Elledge CR, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. Journal of the National Cancer Institute 85: 200\u2013206, 1993","journal-title":"Journal of the National Cancer Institute"},{"key":"BF01806187_CR32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00666204","volume":"32","author":"RM Elledge","year":"1994","unstructured":"Elledge RM, Allred DC: The p53 tumor suppressor gene in breast cancer. Breast Cancer Research and Treatment 32: 39\u201347, 1994","journal-title":"Breast Cancer Research and Treatment"},{"key":"BF01806187_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4615-2592-9_3","volume-title":"Mammary Tumorigenesis and Malignant Progression","author":"MC King","year":"1994","unstructured":"King MC, Rowell S: Genetic analysis of breast and ovarian cancer in families. In: Dickson RB, Lippman ME (eds) Mammary Tumorigenesis and Malignant Progression. Kluwer Academic Publishers, Boston\/Dordrecht\/London, 1994, p 51"},{"key":"BF01806187_CR34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/1097-0142(19900401)65:7<1577::AID-CNCR2820650721>3.0.CO;2-D","volume":"65","author":"S Keyhani-Rofagha","year":"1990","unstructured":"Keyhani-Rofagha S, O'Toole RV, Farrar WB, Sickle-Santanello B, DeCenzo J, Young D: Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma? Cancer 65: 1577\u20131581, 1990","journal-title":"Cancer"},{"key":"BF01806187_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00666350","volume":"28","author":"KW Gilchrist","year":"1993","unstructured":"Gilchrist KW, Gray R, van Driel-Kulker A, Mesker WE, Ploem-Zaaijer JJ, Ploem JS, Taylor SG, Tormey DC: High DNA content and prognosis in lymph node positive breast cancer. A case control study by the university of Leiden and ECOG. Breast Cancer Research and Treatment 28: 1\u20138, 1993","journal-title":"Breast Cancer Research and Treatment"},{"issue":"Supplement","key":"BF01806187_CR36","first-page":"2152","volume":"71","author":"JC Batsakis","year":"1993","unstructured":"Batsakis JC, Sneige N, el-Naggar AK: Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer. Cancer 71 (Supplement): 2152\u20132153, 1993","journal-title":"Cancer"},{"key":"BF01806187_CR37","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/1097-0142(19940915)74:6<1752::AID-CNCR2820740618>3.0.CO;2-5","volume":"74","author":"TE Witzig","year":"1994","unstructured":"Witzig TE, Ingle JN, Cha SS, Schaid DJ, Tabery RL, Wold LE, Grant C, Gonchoroff NJ, Katzmann JA: DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer 74: 1752\u20131761, 1994","journal-title":"Cancer"},{"key":"BF01806187_CR38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.1994.12.7.1422","volume":"12","author":"CL Loprinzi","year":"1994","unstructured":"Loprinzi CL, Ravdin PM, Laurentiis M, Novotny P: Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? Journal of Clinical Oncology 12: 1422\u20131426, 1994","journal-title":"Journal of Clinical Oncology"},{"key":"BF01806187_CR39","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJM199206253262607","volume":"326","author":"WL McGuire","year":"1992","unstructured":"McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl Med 326: 1756\u20131761, 1992","journal-title":"N Engl Med"},{"issue":"Supplement","key":"BF01806187_CR40","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/1097-0142(19920915)70:4+<1775::AID-CNCR2820701619>3.0.CO;2-8","volume":"70","author":"WL McGuire","year":"1992","unstructured":"McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM: Prognosis and treatment decisions in patients with breast cancer without axillary node involvement. Cancer 70 (Supplement): 1775\u20131781, 1992","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806187\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:50:32Z","timestamp":1557496232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF01806187"],"URL":"https:\/\/doi.org\/10.1007\/bf01806187","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}